Evidence map›Paper›PMID 35070081›Full record

ArticleOncotarget2022

Seventh BHD international symposium: recent scientific and clinical advancement.

Mark R Woodford, Avgi Andreou, Masaya Baba, Irma van de Beek, Chiara Di Malta, Iris Glykofridis, Hannah Grimes, Elizabeth P Henske, Othon Iliopoulos, Masatoshi Kurihara and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Monogenic Kidney Diseases in Kidney Transplantation.Kidney international reports · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Mark R WoodfordDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Avgi AndreouDepartment of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Masaya BabaInternational Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan.
Irma van de BeekDepartment of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Chiara Di MaltaTelethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Iris GlykofridisAmsterdam UMC, Location VUmc, Human Genetics Department, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Hannah GrimesCambridge Institute for Medical Research, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Elizabeth P HenskeCenter for LAM Research and Clinical Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Othon IliopoulosCenter for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Masatoshi KuriharaPneumothorax Research Center and Division of Thoracic Surgery, Nissan Tamagawa Hospital, Setagayaku, Tokyo, Japan.
Romain LazorRespiratory Medicine Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
W Marston LinehanUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Kenki MatsumotoDepartment of Respiratory Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Stefan J MarciniakCambridge Institute for Medical Research, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Yukiko NambaDivision of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Arnim PauseDepartment of Biochemistry, Goodman Cancer Research Institute, McGill University, Montréal, Canada.
Neil RajanTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Anindita RayIndian Statistical Institute, Kolkata, WB, India.
Laura S SchmidtBasic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Wei ShiThe Saban Research Institute, Children's Hospital Los Angeles, The Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Ortrud K SteinleinInstitute of Human Genetics, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
Julia ThieraufDepartment of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Roberto ZoncuDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, USA.
Anna WebbThe BHD Foundation, The Myrovlytis Trust, London, UK.
Mehdi MollapourDepartment of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.

Funding

Molecular Therapeutics of Kidney Cancer: MET Gene and BHD GeneZIABC011043 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$20.9M
Clinical Nursing and Data Management CoreZIDBC011089 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$17.4M
Regulatory mechanisms of the Hsp90 chaperone machinery.R35GM139584 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2021 to 2025
$2.2M
Crosstalk between post-translational regulations of the FNIP co-chaperones and their impact on Hsp90 chaperone function and drug bindingR01GM124256 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI MOLLAPOUR, MEHDI · 2017 to 2020
$1.3M
Cancer Research UKCCR NIH HHS HHSN261200800001CCIHR PJT-165829CIHR PJT-247494Department of HealthMedical Research Council G1002610Medical Research Council MR/R009120/1Medical Research Council MR/V028669/1NCI NIH HHS HHSN261200800001ENIGMS NIH HHS R01 GM124256NIGMS NIH HHS R35 GM139584
6 · The paper itself

Abstract

The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients' experiences living with this malady.

Indexed as

Birt-Hogg-Dube SyndromeHumansBirt-Hogg-Dubé syndromeFLCNfolliculinLDHAtuberous sclerosis complex

Identifiers

PMID35070081
PMCPMC8780807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.